Tailored pharmacokinetic dosing allows self-administration and reduces the cost of IV augmentation therapy with human alpha(1)-antitrypsin. [electronic resource]

By: Contributor(s): Producer: 20030930Description: 151-6 p. digitalISSN:
  • 0031-6970
Subject(s): Online resources: In: European journal of clinical pharmacology vol. 59
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't

There are no comments on this title.

to post a comment.